‘CASCADE’ Network Organizational Units

The ‘CASCADE’ Network consists of the following organizational units: one Network Coordinating Center (supported via RFA-CA-21-045), three Research Bases (supported via RFA-CA-21-046), and nine Clinical Sites (three sites supported via RFA-CA-21-047; six additional sites supported via RFA-CA-22-051).

Organizational Unit

Principal Investigator(s)

Institution(s)

Grant No.

CASCADE Network Coordinating Center (CNCC)

Suzanne Siminski, M.S., M.B.A., and KyungMann Kim, Ph.D.

Frontier Science, with
University of Wisconsin

U24CA275417

Research Base 1 (RB1)

Rachel Winer, Ph.D., M.P.H. and
Elizabeth Brown, Sc.D., M.S.

University of Washington, with
Fred Hutchinson Cancer Research Center

UG1CA275402

Research Base 2 (RB2)

Timothy Wilkin, M.D., M.P.H., Anna Giuliano, Ph.D., and
Carla Chibwesha, M.D., M.Sc.

Weill Medical College of Cornell University, with Moffitt Cancer Center and University of North Carolina at Chapel Hill

UG1CA275414

Research Base 3 (RB3)

Jennifer Smith, Ph.D., M.P.H., Michael Hudgens, Ph.D., and Lameck Chinula, M.D., M.P.H.

University of North Carolina at Chapel Hill

UG1CA275403

Clinical Trials Site 1 (CS1): Uganda

Betty Mwesigwa, M.B.Ch.B., M.Sc.

Makerere University Walter Reed Project, with US Military HIV Research Program and Uganda Cancer Institute

UG1CA275412

Clinical Trials Site 2 (CS2): Kenya

Michael Chung, M.D., Ph.D., M.P.H. and Samah Sakr, M.B.Ch.B.

Emory University, with Coptic Hope Center for Infectious Diseases and Kenyatta National Hospital

UG1CA275400

Clinical Trials Site 3 (CS3): Botswana

Scott Dryden-Peterson, M.D., M.S. and Doreen Ramogola-Masire, M.B.B.S., Ph.D., M.P.H.

Brigham and Women's Hospital, with Botswana Harvard AIDS Institute Partnership

UG1CA275416

Clinical Trials Site 4 (CS4): US/Georgia

Lisa Flowers, M.D., M.P.H. and

Anandi Sheth, M.D., M.Sc.

 

Emory University

UG1CA284884

Clinical Trials Site 5 (CS5): Rwanda

Gad Murenzi, M.D., M.S., Kathryn Anastos, M.D., and Rubagumya Fidel, M.D., M.P.H.

 

Research for Development, Albert Einstein College of Medicine, with Rwanda Military Hospital

UG1CA284908

Clinical Trials Site 6 (CS6): Kenya

Nelly Mugo, M.B.Ch.B., M.P.H., and Kenneth Ngure, Ph.D., M.P.H., M.Sc.

 

Kenya Medical Research Institute (KEMRI), with Jomo Kenyatta University of Agriculture and Technology

UG1CA285132

Clinical Trials Site 7 (CS7): Zimbabwe

Chirenje Zvavahera, M.D., and Bothwell Guzha, M.B.Ch.B, M.Phil

 

University of California, San Francisco, with University of Zimbabwe

UG1CA284918

Clinical Trials Site 8 (CS8): US/Maryland

Clement Adebamowo, B.M.Ch.B., Sc.D., and Gregory Taylor, M.D.

 

University of Maryland, Baltimore

UG1CA284883

Clinical Trials Site 9 (CS9): South Africa

Nivashnee Naicker, M.D., M.P.H, M.A.S.

Centre for the AIDS Programme of Research in South Africa (CAPRISA)

UG1CA284671